Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: June 2017

New Report: More Than 50 Medicines and Vaccines in Development for HIV Infection, Treatment and Prevention

Washington, DC, June 30, 2017 — The Pharmaceutical Research and Manufacturers of America (PhRMA) reports that America’s biopharmaceutical companies are continuing the fight to conquer the human immunodeficiency virus (HIV), which can develop into acquired immune deficiency syndrome (AIDS).

According to a new report released on June 27 by PhRMA in partnership with The AIDS Institute, 52 medicines and vaccines are currently in development to help treat and prevent the infection.

Among the 52 medicines in development for HIV, there are 32 antiretrovirals and antivirals, 16 vaccines and four cell therapies, including a potential first-in-class medicine intended to prevent HIV from attaching to new cells and breaking through the cell membrane. Continue reading

Quinnipiac Poll: U.S. Voters Reject GOP Health Plan More Than 3-1; Oppose Medicaid and Planned Parenthood Cuts

Hamden, Connecticut, June 29, 2017 — Despite its new name and some tweaks, American voters disapprove 58 to 16 percent of the Republican health care plan to replace Obamacare, according to a Quinnipiac University national poll released June 28.

Disapproval of various versions of the Republican health care plan ranges from 56 to 21 percent to 62 to 17 percent in surveys by the independent Quinnipiac University conducted since March.

On March 24, the House of Representatives cancelled a vote on its first health care bill after a Quinnipiac University poll showed voters disapproved 56 to 17 percent. Continue reading

Rutgers Launches TechAdvance Funding Program to Advance Inventions Toward Commercialization

New Brunswick, NJ, June 29, 2017 — The Office of Research Commercialization (ORC) announces TechAdvance, a new fund created to advance Rutgers technologies toward commercialization.

The fund offers grants of up to $100,000 for promising technologies in areas including life science, physical science, engineering, agriculture and IT that have strong potential for commercial success but are “too early” for investors or industry partners. Continue reading

PhRMA Releases ‘Research in Your Backyard’ for New Jersey; PhRMA, HINJ and WWFH-NJ Host Discussion Focused on Biopharma Research in Garden State

New Brunswick, NJ, June 28, 2017 — The Pharmaceutical Research and Manufacturers of America (PhRMA) today released a new report titled “Research in Your Backyard: Developing Cures, Creating Jobs, Pharmaceutical Clinical Trials in New Jersey,” which finds that 25,127 New Jersey patients participate in clinical trials around the state, generating $617 million in economic growth.

The report was released at an event co-hosted by PhRMA, the HealthCare Institute of New Jersey (HINJ) and We Work for Health New Jersey (WWFH-NJ) that was held at the Rutgers Cancer Institute of New Jersey.

In addition to a presentation of the new PhRMA report, the event featured a panel discussion of industry experts that was moderated by HINJ President and Chief Executive Officer Dean J. Paranicas: Continue reading

Vice President Joe Biden and Dr. Jill Biden Launch Biden Cancer Initiative; Aims to Make Progress in Cancer Prevention, Detection, Treatment, Care

Dr. Jill Biden and Vice President Joe Biden

New York, NY, June 28, 2017 — President Joe Biden and Dr. Jill Biden on June 26 launched the Biden Cancer Initiative, their new venture to continue the fight to make progress in cancer prevention, detection, treatment, and care.

The launch event was highlighted by Vice President and Dr. Biden joining members of the Biden Cancer Initiative Board of Directors for a conversation about the mission of the Initiative, the issues it will address, and the promise of what they hope to accomplish together.

The Biden Cancer Initiative will develop and drive implementation of solutions to accelerate progress in cancer prevention, detection, diagnosis, research and care, and to reduce disparities in cancer outcomes. Continue reading

NPR All Tech Considered: Before Silicon Valley, New Jersey Reigned as Nation’s Center of Innovation

Washington, DC, June 28, 2017Laura Sydell on June 5 reported on National Public Radio (NPR) on New Jersey’s history of innovation:

People from New Jersey are used to defending their state.

But, in fact, New Jersey has a history to brag about. Thomas Edison invented the light bulb, the phonograph and the movie camera there. Many decades later, Bell Labs invented the transistor in the state. Continue reading

HINJ Partners with PILMA and WWFH-NJ to Host Life Sciences-Organized Labor Training Facility Tour for Rep. MacArthur

(L. to r.) HINJ CEO Dean Paranicas, IUOE Local 85 Business Manager Greg Lavelee, Sen. Steve Sweeney and Rep. Tom MacArthur

New Brunswick, NJ, June 27, 2017 — The HealthCare Institute of New Jersey (HINJ), along with the Pharmaceutical Industry-Labor Management Association (PILMA) and We Work For Health – New Jersey (WWFH-NJ), hosted an organized labor training facility tour for Congressman Tom MacArthur (R-NJ-3rd) on May 12.

New Jersey Senate President Stephen M. Sweeney (D-Gloucester) also attended the event, which was held at the International Union of Operating Engineers (IUOE) Local 825 Training Grounds in Dayton, NJ.

To view a video from the tour — including brief comments from Congressman MacArthur and Senate President Sweeney — please click here. Continue reading

Rutgers-New Brunswick Rated One of Top 100 Research Universities in the World; Ranked No. 31 in U.S.

New Brunswick, NJ, June 26, 2017 — NJBIZ reported that Rutgers-New Brunswick was one of 37 universities in the United States to be ranked among the Top 100 research-intensive universities in the world, according to the prestigious CWTS Leiden Rankings.

Rutgers ranked No. 77 in the world, but No. 31 among schools based in the United States.

Rutgers was behind Cornell (No. 26), Washington University in St. Louis (27) and New York University (29). Continue reading

Monmouth University Interim President Grey Dimenna to Stay Until June 2019

Grey Dimenna

West Long Branch, NJ, June 26, 2017 — Grey Dimenna, plucked out of retirement to fill in as president of Monmouth University, has extended his contract and will serve until June 2019, the school said.

Dimenna said the temporary appointment won’t prevent the West Long Branch university from taking steps to tackle pressing issues facing higher education, including its cost.

“Although I’m only going to be president a couple years, there’s a lot of important things to do,” Dimenna, 63, said. “There’s a lot of momentum we need to keep going.” Continue reading

NJEDA: Ideal Location, Unique State Resources Give Enteris BioPharma Advantage in Global Marketplace

Trenton, NJ, June 25, 2017 — This week’s BIO International Convention gave leaders from New Jersey’s vast life sciences ecosystem the chance to show emerging companies the advantages of establishing themselves within the State, such as its ideal location on the Eastern seaboard and the large number of pharmaceutical giants that currently call the State “home.”

“The Garden State is truly the best place to start a biopharmaceutical company,” New Jersey Economic Development Authority (EDA) Chief Executive Officer (CEO) Melissa Orsen said. Continue reading